Farallon Capital Management as of March 31, 2018
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 85 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 15.4 | $2.2B | 8.5M | 263.15 | |
| Nxp Semiconductors N V (NXPI) | 6.7 | $969M | 8.3M | 117.00 | |
| Aetna | 6.7 | $963M | 5.7M | 169.00 | |
| Monsanto Company | 5.4 | $776M | 6.7M | 116.69 | |
| Rockwell Collins | 5.0 | $728M | 5.4M | 134.85 | |
| Altaba | 4.3 | $627M | 8.5M | 74.04 | |
| Dell Technologies Inc Class V equity | 3.6 | $515M | 7.0M | 73.21 | |
| Dr Pepper Snapple | 2.7 | $387M | 3.3M | 118.38 | |
| Wabtec Corporation (WAB) | 2.7 | $386M | 4.7M | 81.40 | |
| Facebook Inc cl a (META) | 2.7 | $388M | 2.4M | 159.79 | |
| Alphabet Inc Class C cs (GOOG) | 2.6 | $377M | 365k | 1031.79 | |
| Visa (V) | 2.3 | $333M | 2.8M | 119.62 | |
| Playa Hotels & Resorts Nv (PLYA) | 2.2 | $313M | 31M | 10.22 | |
| Iqvia Holdings (IQV) | 2.1 | $310M | 3.2M | 98.11 | |
| Transunion (TRU) | 1.8 | $253M | 4.5M | 56.78 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 1.7 | $246M | 790k | 311.22 | |
| Ihs Markit | 1.6 | $237M | 4.9M | 48.24 | |
| Microsoft Corporation (MSFT) | 1.6 | $230M | 2.5M | 91.27 | |
| Anthem (ELV) | 1.5 | $218M | 990k | 219.70 | |
| Citrix Systems | 1.5 | $215M | 2.3M | 92.80 | |
| LogMeIn | 1.4 | $202M | 1.7M | 115.55 | |
| Fox News | 1.3 | $182M | 5.0M | 36.37 | |
| Verisk Analytics (VRSK) | 1.2 | $174M | 1.7M | 104.00 | |
| Equifax (EFX) | 1.1 | $166M | 1.4M | 117.81 | |
| Cavium | 1.0 | $150M | 1.9M | 79.38 | |
| Liberty Global Inc C | 1.0 | $149M | 4.9M | 30.43 | |
| Fidelity National Information Services (FIS) | 1.0 | $147M | 1.5M | 96.30 | |
| Liberty Global Inc Com Ser A | 1.0 | $148M | 4.7M | 31.31 | |
| Radius Health | 1.0 | $147M | 4.1M | 35.94 | |
| Gilead Sciences (GILD) | 0.9 | $137M | 1.8M | 75.39 | |
| Ablynx Nv | 0.9 | $134M | 2.5M | 54.56 | |
| AstraZeneca (AZN) | 0.9 | $125M | 3.6M | 34.97 | |
| IAC/InterActive | 0.8 | $112M | 715k | 156.38 | |
| Time Warner | 0.7 | $97M | 1.0M | 94.58 | |
| Biogen Idec (BIIB) | 0.6 | $93M | 340k | 273.82 | |
| Ascendis Pharma A S (ASND) | 0.6 | $84M | 1.3M | 65.40 | |
| Fibrogen (FGEN) | 0.6 | $79M | 1.7M | 46.20 | |
| Xl | 0.5 | $75M | 1.4M | 55.26 | |
| Enanta Pharmaceuticals (ENTA) | 0.5 | $74M | 915k | 80.91 | |
| Express Scripts Holding | 0.5 | $72M | 1.0M | 69.08 | |
| Sage Therapeutics (SAGE) | 0.5 | $72M | 445k | 161.07 | |
| Iovance Biotherapeutics (IOVA) | 0.5 | $70M | 4.2M | 16.90 | |
| Hrg | 0.5 | $67M | 4.0M | 16.49 | |
| Zogenix | 0.4 | $63M | 1.6M | 40.05 | |
| Acceleron Pharma | 0.4 | $55M | 1.4M | 39.10 | |
| Qualcomm (QCOM) | 0.4 | $53M | 960k | 55.41 | |
| Amicus Therapeutics (FOLD) | 0.4 | $52M | 3.5M | 15.04 | |
| Bunge | 0.3 | $51M | 690k | 73.94 | |
| Array BioPharma | 0.3 | $51M | 3.1M | 16.32 | |
| Myokardia | 0.3 | $51M | 1.0M | 48.80 | |
| Xpo Logistics Inc equity (XPO) | 0.3 | $48M | 475k | 101.81 | |
| Alnylam Pharmaceuticals (ALNY) | 0.3 | $44M | 370k | 119.10 | |
| Novocure Ltd ord (NVCR) | 0.3 | $40M | 1.9M | 21.80 | |
| Veon | 0.3 | $41M | 16M | 2.64 | |
| Avexis | 0.2 | $36M | 294k | 123.58 | |
| Sutherland Asset Management reit | 0.2 | $34M | 2.2M | 15.15 | |
| CIGNA Corporation | 0.2 | $30M | 180k | 167.74 | |
| Galapagos Nv- (GLPG) | 0.2 | $31M | 308k | 99.76 | |
| Crispr Therapeutics (CRSP) | 0.2 | $30M | 645k | 45.71 | |
| Bemis Company | 0.2 | $25M | 563k | 43.52 | |
| Avista Corporation (AVA) | 0.1 | $21M | 400k | 51.25 | |
| Savara (SVRA) | 0.1 | $21M | 2.2M | 9.20 | |
| Hain Celestial (HAIN) | 0.1 | $18M | 545k | 32.07 | |
| Voyager Therapeutics (VYGR) | 0.1 | $17M | 890k | 18.79 | |
| Amarin Corporation (AMRN) | 0.1 | $14M | 4.6M | 3.01 | |
| Envision Healthcare | 0.1 | $14M | 365k | 38.43 | |
| Chemocentryx | 0.1 | $13M | 950k | 13.60 | |
| Tronox | 0.1 | $13M | 688k | 18.44 | |
| Intellia Therapeutics (NTLA) | 0.1 | $14M | 650k | 21.09 | |
| Zealand Pharma A/s- | 0.1 | $13M | 865k | 15.02 | |
| Chicago Bridge & Iron Company | 0.1 | $9.5M | 660k | 14.40 | |
| Audentes Therapeutics | 0.1 | $9.6M | 320k | 30.05 | |
| Aspen Insurance Holdings | 0.1 | $8.7M | 194k | 44.85 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.1 | $8.3M | 393k | 21.20 | |
| Mirati Therapeutics | 0.1 | $8.3M | 270k | 30.70 | |
| Voya Financial (VOYA) | 0.1 | $9.3M | 185k | 50.50 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $8.7M | 1.0M | 8.59 | |
| Synlogic | 0.1 | $9.1M | 975k | 9.38 | |
| Cymabay Therapeutics | 0.1 | $7.1M | 550k | 12.99 | |
| Vici Pptys (VICI) | 0.0 | $6.1M | 337k | 18.00 | |
| Xencor (XNCR) | 0.0 | $4.5M | 150k | 29.98 | |
| Glycomimetics (GLYC) | 0.0 | $4.1M | 250k | 16.23 | |
| Sanofi Aventis Wi Conval Rt | 0.0 | $2.9M | 6.8M | 0.42 | |
| Tyme Technologies | 0.0 | $3.2M | 1.4M | 2.23 | |
| Arcus Biosciences Incorporated (RCUS) | 0.0 | $176k | 11k | 15.41 |
